Reply to Hardalo Et Al., “Myelosuppression With Oxazolidinones: Are There Differences?”

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01973-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Myelosuppression With Oxazolidinones: Are There Differences?

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Reply to Biskup Et Al. And Tu Et Al.: Sex Differences in Metabolic Brain Aging

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Reply to Castillo Et Al.

American Journal of Hematology
Hematology
2018English

Reply to Ryser Et Al.

International Journal of Cancer
Cancer ResearchOncology
2017English

Reply to Claoué Et Al

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2012English

Reply to Zimmerman Et Al

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2012English

Reply to Lauhio Et Al

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2015English

Reply to Serin Et Al.

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2017English

Reply to O'Grady Et Al.

Physiological Reviews
MedicinePhysiologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy